Uden DL - Search Results

1

Evaluation of a rapid monitoring system to study heparin pharmacokinetics and pharmacodynamics.

Cipolle RJ, Uden DL, Gruber SA, Jossart GH, Taylor CA, Erdmann GR, Canafax DM. Cipolle RJ, et al. Among authors: uden dl. Pharmacotherapy. 1990;10(6):367-72. Pharmacotherapy. 1990. PMID: 2287554

2

The effect of heparin on three whole blood activated clotting tests and thrombin time.

Uden DL, Seay RE, Kriesmer PJ, Cipolle RJ, Payne NR. Uden DL, et al. ASAIO Trans. 1991 Apr-Jun;37(2):88-91. ASAIO Trans. 1991. PMID: 1854557

3

Bronchodilation from intravenous theophylline in patients with cystic fibrosis: results of a blinded placebo-controlled crossover clinical trial.

Pan SH, Canafax DM, Le CT, Cipolle RJ, Uden DL, Warwick WJ. Pan SH, et al. Among authors: uden dl. Pediatr Pulmonol. 1989;6(3):172-9. doi: 10.1002/ppul.1950060309. Pediatr Pulmonol. 1989. PMID: 2654849 Clinical Trial.

4

Procedural variables which affect activated clotting time test results during extracorporeal membrane oxygenation therapy.

Uden DL, Payne NR, Kriesmer P, Cipolle RJ. Uden DL, et al. Crit Care Med. 1989 Oct;17(10):1048-51. doi: 10.1097/00003246-198910000-00016. Crit Care Med. 1989. PMID: 2791566

5

Pharmacokinetics of fluconazole in immune-compromised children with leukemia or other hematologic diseases.

Seay RE, Larson TA, Toscano JP, Bostrom BC, O'Leary MC, Uden DL. Seay RE, et al. Among authors: uden dl. Pharmacotherapy. 1995 Jan-Feb;15(1):52-8. Pharmacotherapy. 1995. PMID: 7739946

6

Inactivation of heparin during extracorporeal circulation in infants.

Green TP, Isham-Schopf B, Irmiter RJ, Smith C, Uden DL, Steinhorn RH. Green TP, et al. Among authors: uden dl. Clin Pharmacol Ther. 1990 Aug;48(2):148-54. doi: 10.1038/clpt.1990.129. Clin Pharmacol Ther. 1990. PMID: 2379386

7

Clinical efficacy of antimicrobial drugs for acute otitis media: metaanalysis of 5400 children from thirty-three randomized trials.

Rosenfeld RM, Vertrees JE, Carr J, Cipolle RJ, Uden DL, Giebink GS, Canafax DM. Rosenfeld RM, et al. Among authors: uden dl. J Pediatr. 1994 Mar;124(3):355-67. doi: 10.1016/s0022-3476(94)70356-6. J Pediatr. 1994. PMID: 8120703

8

Activated clotting time tests with heparinase in the management of pediatric patients on cardiopulmonary bypass.

Kriesmer P, Payne NR, Tessmer J, Uden DL. Kriesmer P, et al. Among authors: uden dl. ASAIO J. 1993 Oct-Dec;39(4):942-5. ASAIO J. 1993. PMID: 8123932

9

The effect of paraldehyde on intravenous tubing sets.

Schallinger LE, Uden DL. Schallinger LE, et al. Among authors: uden dl. Pharmacotherapy. 1989;9(6):381-5. doi: 10.1002/j.1875-9114.1989.tb04153.x. Pharmacotherapy. 1989. PMID: 2616353

10

Predictive performance of three methods of activated clotting time measurement in neonatal ECMO patients.

Seay RE, Uden DL, Kriesmer PJ, Payne NR. Seay RE, et al. Among authors: uden dl. ASAIO J. 1993 Jan-Mar;39(1):39-42. ASAIO J. 1993. PMID: 8439678

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters